ESC 365 - Doctor Tuukka Tarvasmaki

Speaker illustration

Doctor Tuukka Tarvasmaki

Helsinki University Hospital, Helsinki (Finland)

Presentations Articles

Prognostic value of proenkephalin in mortality prediction in cardiogenic shock

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Hemodynamic alterations and 90-day mortality in cardiogenic shock complicated by acute kidney injury

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Prognosis (Syncope)

Session: Acute heart failure

Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients

Event: HEART FAILURE 2016

Topic: Acute heart failure (management)

Session: Acute heart failure

Adrenaline use is related to prominent deterioration in cardiac and renal biomarker profiles in cardiogenic shock

Event: HEART FAILURE 2016

Topic: Acute heart failure (other)

Session: Acute heart failure

Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock

Event: HEART FAILURE 2016

Topic: Acute heart failure (other)

Session: Rapid Fire 1 - Acute heart failure

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources